Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:1.11.1.7 (peroxidase)
 65,474 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

To evaluate the clinical significance of monoclonal antibody against human pulmonary surfactant apoprotein (S-AP), surgically resected lung cancer from 122 patients was studied. Paraffin embedded tissues were used for the immunohistochemical study by the avidin-biotin-peroxidase complex method. The results were as follows. 1. Adenocarcinoma showed highest immunoreactivity for S-AP compared to the other histologic types. Among subtypes of adenocarcinoma, type II alveolar epithelial type, clara cell type and mixed type of these two types were strongly positive (100%, 77.8% and 66.7% respectively). These results indicate that this antibody may be a good marker for the subtyping of adenocarcinoma. 2. There were some positive cases in other histologic types especially in peripheral type of squamous cell carcinoma. These findings suggest that this antibody was useful for the histological differentiation of lung cancer. 3. As to the immunohistochemical reactivity there was a good correlation between tissue and cytological specimens, which indicate cytological studies may be adequate for this kind of histopathological studies. 4. In our study, there were no patients with S-AP positive carcinomas other than patients with lung cancer. These results indicate that this antibody could be used for the differential diagnosis between primary and secondary lung cancer.
 ...
PMID:[Immunohistochemical study of lung cancer using monoclonal antibody against human pulmonary surfactant apoprotein]. 166 33

Lung sections of 104 newborn infants stored for 20 to 25 years and of seven cases of paraquat (PQ) intoxication were examined to detect the pulmonary surfactant apoprotein with the monoclonal antibody PE10 by immunoperoxidase staining technique. Specific peroxidase staining was observed in alveolar Type II cells and on alveolar walls of normal adult lungs. In the lungs of liveborn infant up to 28 weeks' gestation, peroxidase staining was negative. However, faint positive staining was observed in a specimen of 29 weeks' gestation, and the rate of positive staining increased with gestational age. Fifteen cases of newborn lungs with hyaline membranes revealed no positive staining except one. In the lungs of stillborn infants, peroxidase staining was weak and the rate of negative staining was more than that of liveborn infants. The specimens of PQ intoxication up to 5 days survival showed positive staining on alveolar walls, while those of 10 days or more survival, in which fibrotic changes and hyaline membranes were developed, showed no positive staining.
 ...
PMID:Evaluation of monoclonal antibody against human pulmonary surfactant apoprotein. 328 1